Aterian, Inc. (NASDAQ:ATER – Get Free Report) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 286,100 shares, an increase of 10.8% from the November 15th total of 258,300 shares. Currently, 4.2% of the company’s shares are short sold. Based on an average daily trading volume, of 53,000 shares, the days-to-cover ratio is currently 5.4 days.
Institutional Investors Weigh In On Aterian
Hedge funds and other institutional investors have recently made changes to their positions in the business. Essex Investment Management Co. LLC bought a new stake in Aterian during the third quarter worth $102,000. XTX Topco Ltd purchased a new position in Aterian during the 2nd quarter worth $59,000. Finally, Jane Street Group LLC bought a new stake in shares of Aterian in the 3rd quarter worth $33,000. 7.02% of the stock is owned by institutional investors.
Aterian Price Performance
Shares of ATER opened at $2.34 on Monday. The stock has a 50-day moving average of $2.73 and a 200-day moving average of $2.80. Aterian has a one year low of $1.90 and a one year high of $6.54. The company has a market cap of $20.49 million, a PE ratio of -0.86 and a beta of 2.04.
About Aterian
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
Recommended Stories
- Five stocks we like better than Aterian
- Investing In Automotive Stocks
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
- What is Forex and How Does it Work?
- Best Ultra-Value Stocks Set for Long-Term Growth
- Best Stocks Under $5.00
- E-Commerce Giant PDD Looks Due For a Big Comeback in 2025
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.